EUVIMEDEUVIMED entdecken
Crossref

Thermosensitive gel-nano system against esophageal cancer via restoring p53 activity and boosting T-cell immunity

Ke Gong, Jiangtao Lin, Xiaoyan Chen, Yi Duan, Jiali Zhang, Jian Yu, Jing Wang, Ruifang Sun, Jie Li, Yourong Duan

Journal of Controlled Release · 2024

DOI: 10.1016/j.jconrel.2024.05.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Ke Gong und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Sh…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Tumor Suppressor Protein p53, Nanoparticles. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In esophageal cancer (EC), clinical specimen testing has uncovered a significant increase in BTB and CNC homolog 1 (BACH1) expression and a shift towards an immunosuppressive environment, alongside a notable decrease in p53 protein expression. Therefore, therapeutic strategies focusing on BACH1 inhibition and p53 upregulation appear promising. Traditional oral treatments for EC lack precision and efficacy. Here, we propose a novel approach employing tumor-targeted nanoparticles (NPs) for drug delivery. However, the formation of a drug reservoir at the esophageal site, crucial for the sustained release of therapeutics, presents significant challenges in nano-delivery systems for EC treatment. To address this, we developed a thermosensitive hydrogel composed of F127 and tannic acid, serving as a vehicle for NP loading. These NPs, synthesized through the emulsion/volatization methods of mPEG-PLGA-PLL-cRGD, facilitate in situ drug delivery. Upon contacting esophageal tissue, the hydrogel transitions to a gel, adhering to the lining and enabling sustained release of encapsulated therapeutics. The formulation encompasses NPs laden with small interfering RNA targeting BACH1 (siBACH1) and the p53 activator PRIMA-1, creating a cohesive gel-nano system. Preliminary biological assessments demonstrate that this injectable, thermosensitive gel-nano system adheres effectively to esophageal tissue and targets EC cells. For better modeling clinical outcomes, a patient-derived organoid xenograft (PDOX) model was innovated, involving transplantation of EC-derived organoids into humanized mice, reconstructed with peripheral blood mononuclear cells (PBMCs). Post-treatment analysis showed substantial EC growth inhibition (89.51% tumor inhibition rate), significant BACH1 level reduction, restored anti-tumor immune responses, and pronounced tumor apoptosis. In summary, our study introduces a thermosensitive gel-nano system for EC treatment via restoring p53 activity and boosting T-cell immunity, with potential for clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsTumor Suppressor Protein p53NanoparticlesAnimalsHumansCell Line, TumorHydrogelsT-LymphocytesFemaleMiceTemperatureAntineoplastic AgentsDrug Delivery Systems

Stichwörter der Autor:innen

BACH1 inhibitionEsophageal cancerNanoparticleThermosensitive hydrogelp53 activation

Substanzen

Tumor Suppressor Protein p53HydrogelsAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China.
  • Department of Pathology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China.
  • Department of Radiation Oncology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shan…
  • Department of Tumor Biobank, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi 0…
  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200032, China. Electronic address: yrduan@shsci.org.

Zitieren

APA

Gong, K., Lin, J., Chen, X., Duan, Y., Zhang, J., Yu, J., Wang, J., Sun, R., Li, J., & Duan, Y. (2024). Thermosensitive gel-nano system against esophageal cancer via restoring p53 activity and boosting T-cell immunity. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.05.040

Vancouver

Gong K, Lin J, Chen X, Duan Y, Zhang J, Yu J, et al. Thermosensitive gel-nano system against esophageal cancer via restoring p53 activity and boosting T-cell immunity. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.05.040

BibTeX
@article{Gong2024,
  author = {Gong, Ke and Lin, Jiangtao and Chen, Xiaoyan and Duan, Yi and Zhang, Jiali and Yu, Jian and Wang, Jing and Sun, Ruifang and Li, Jie and Duan, Yourong},
  title = {Thermosensitive gel-nano system against esophageal cancer via restoring p53 activity and boosting T-cell immunity},
  journal = {Journal of Controlled Release},
  year = {2024},
  doi = {10.1016/j.jconrel.2024.05.040}
}
Kostenlos starten →